Given the first case registration of the BA.2.75 subline in Peru, known as the centaur, experts point to the need to strengthen preventive measures and vaccines to be properly protected against COVID-19. Take four doses of
In this regard, infectious diseases specialist from the National Hospital Cayetano Heredia, Leslie Sotoexplained that the centaur sublineage is ten times more infectious than the other sublineages of the Omicron variant.
Along these lines, he emphasized on the need for people to receive the respective doses of the COVID-19 vaccine so that their bodies can be protected from the appearance of these new sub-categories.
“Those who are hospitalized are patients who have received two doses or three doses of the vaccine for more than five months, so it is very important to prevent this infection,” he said.
Soto commented that the centaur sublineage is a sub-lineage of BA.2, which in turn is the son of the Omicron variant, and was identified in India in May of this year.
“The centaur sublineage is more contagious than the ba.4 and ba.5 subvariants. People think the virus is cool, but that’s false. It’s just as aggressive, only we handle it like the flu because we’d have been vaccinated.” is,” he mentioned.
He added that people who have not been vaccinated and have risk factors can be as complicated as the first wave.
Regarding the symptoms, he indicated that it is similar to Omicron, it starts with general malaise, flu, sore throat and a lot of annoyance. “We hope it is not complicated by a lack of oxygen,” he said.
In India, this lineage represents at least 23% of sequenced infections and grows faster than the rest of the BA.2 lineage at a rate of 17% per day, according to data from the Peruvian National Institutes of Health.
To date, centaurs have been identified in countries such as Germany, Australia, Canada, Japan, New Zealand, the United Kingdom and the United States, but have not yet been identified in South America.
In this sense, Minsa urges the population to continue vaccination and adhere to safeguards against COVID-19, as the country has seen an increase in virus infections over the past week.
Vaccine effectiveness

The doctor indicated that the vaccines are less effective than they were currently introduced, which is why bivalent vaccines are being introduced, which can protect against different types and subtypes of COVID-19.
“They’re not implementing them yet because they’re in phase three of the study, but they’re about to come out and there’s a good increase in their defense,” he said.
When asked about the effectiveness of the vaccines that have been given to us in the country, he said that they protect us, but not 90% as before, but at least 75% or 80 to avoid hospitalization. % more than.
“We have the memory to defend, we are growing to be able to defend better against COVID-19,” he concluded.
More on endian:
Changing symptoms of COVID-19: what are currently the most common? , https://t.co/WAsMs3m5fo
Yuri Kondor, medical epidemiologist and head of health intelligence at VES Emergency Hospital, said fever is no longer the main symptom. pic.twitter.com/n6WQ3rIFEQ
— Andean Agency (@Agencia_Andina) 21 July 2022
(fin) jam / lit